NP / PA
Hughes, Kathleen
Hughes, Kathleen was paid $536K by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoHUGHES, KATHLEEN
LINCOLN, RI 02865
LINCOLN, RI 02865
33aNPI1174965974assigned 07/22/2013
33bProvider typePediatric Nurse Practitioner
28Total paid$536K
24GClaims7,570
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Rhode Island
Rank by total paid#1 of 28
Median peer was paid$49K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,246 | $48K | |
| 2019 | 303 | $12K | |
| 2020 | 816 | $38K | |
| 2021 | 1,276 | $66K | |
| 2022 | 1,198 | $92K | |
| 2023 | 1,585 | $163K | |
| 2024incomplete | 1,146 | $118K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 2,799 | 2,596 | $188K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 1,187 | 1,130 | $122K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.9% | 356 | 295 | $48K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.7% | 799 | 643 | $47K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.9% | 150 | 142 | $21K |
| 90461 | 3.3% | 282 | 243 | $18K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 182 | 172 | $17K |
| 87428 | 2.5% | 252 | 250 | $14K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 160 | 155 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.6% | 42 | 42 | $9K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 38 | 37 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 402 | 393 | $8K |
13 more codes
| 99050 | <1% | 152 | $5K | |
| 99051 | <1% | 113 | $4K | |
| 92552 | <1% | 189 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 27 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 25 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 191 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 77 | $2K |
| 96161 | <1% | 29 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 28 | $861.34 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13 | $439.11 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $158.21 |
| 96127 | <1% | 12 | $37.95 | |
| 90686 | <1% | 52 | $26.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.